During fiscal year 2026, the company maintained production of its ADHD medications, Adzenys and Cotempla, without experiencing supply chain interruptions that had impacted the industry in previous years. The company's suppliers identified in filings include Acerus Pharmaceuticals, Cerecor, EnzCo, LLC, Merck & Cie, and Tris Pharma.
Aytu Biopharma Inc's Comment on Supply Chain
During fiscal year 2026, the company maintained production of its ADHD medications, Adzenys and Cotempla, without experiencing supply chain interruptions that had impacted the industry in previous years. The company's suppliers identified in filings include Acerus Pharmaceuticals, Cerecor, EnzCo, LLC, Merck & Cie, and Tris Pharma.
Sources:
Aytu Biopharma Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Aytu Biopharma Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
